What is LabMed National Audit Day?

LabMed’s National Audit Day is a dedicated one-day event showcasing the latest national and regional clinical audits in laboratory medicine, led by Clinical Scientists and Medical professionals across the UK.

Whether you’re directly involved in audits, use audit data to improve patient care, or want to stay ahead of developments in diagnostic service quality — this is an essential event to attend.

Why attend?

Hear firsthand about current and future national audits, and how they’re shaping best practice
Learn from leading experts in prostate cancer, testosterone, menopause, and tumour marker diagnostics
Engage in discussion with peers and national leads on improving quality across laboratory medicine
Network with professionals and explore audit posters from across the UK
CPD opportunity – supporting your continued professional development

Who should attend?

Clinical Scientists
Laboratory Medicine Consultants
Pathology audit leads
Trainees
Quality Managers
Anyone involved in clinical audit, service improvement, or diagnostics

Abstracts now open

Abstracts are now open to be considered for both oral and/or poster presentation at the forthcoming National Audit Meeting. Submission can be made via the form below. Deadline for submission is 5pm 19 September 2025.

Submitted abstracts are scored anonymously by the members of the LabMed National Audit committee.

• Two abstracts will be chosen by the National Audit Group for oral presentation. However, if you do not wish for your abstract to be considered for oral presentation, this can be indicated on the form. 
• The top 10 abstracts will be published on the Annals website.

The posters at the meeting are judged on the day by the delegates of the meeting. Presenters must be registered delegates at the meeting and should normally be the lead author of the audit.

Submitting your abstract
Abstracts (300 words maximum, excluding author(s) and title) should be submitted in word format and cover the followings areas:

• Title:
• Authors:
• Aim:
• Standards / Guidelines:
• Audit Method:
• Summary of Results:
• Outcome: Audit Recommendations

You can download this word template with the required headings. 

Abstract submission template

Programme

9.30am  Welcome and introduction, W Wassif, National Audit Lead
9.35am  National audit of the laboratory investigation of PSA for the diagnosis and monitoring of prostate cancer, Andrew Seggie, Prostate Cancer UK
10.05am  Detection, assessment, surveillance, and management of prostate cancer, Caroline Moore, Professor and Honorary Consultant Urological Surgeon University College Hospital, London

10.45am  Tea Break

11.00am  National Audit on testosterone, Nicola Barlow, Black Country Pathology Services 
11.40am  Outcomes of testosterone treatment in Pathological and functional male hypogonadism, Richard Quinton, Consultant Endocrinologist, Newcastle Hospitals Trust 
12.10am Clinical presentation, TBC
12.25am  Menopause and HRT in females (including testosterone), TBC
12.50am  Discussion

1.00pm Lunch and poster session

2.00pm Regional audit presentations x 2, TBC
2.30pm  National audit on tumours markers, Louise Ward, Bedford Hospital NHS Trust and Peter West, South Thames Audit Group
3.00pm  The provision of laboratory service for tumour markers, Cathie Sturgeon UK NEQAS, Edinburgh Royal Infirmary

3.30pm  Tea break

3.45pm  Circulating DNA (ctDNA): A potentially Transformative Tumour Marker, Michael Duffy Professor at Clinical Research Centre St Vincent's University Hospital, Dublin, Ireland
4.10pm  Title TBC, Kathryn Hawkesford Consultant Medical Oncologist, Barts Health NHS Trust
4.50pm  Discussion
5.00pm  Feedback and closing remarks, W Wassif, National Audit Lead